FOLD Insider Holders & Insider Ownership - AMICUS THERAPEUTICS INC.

List of insiders holdings for AMICUS THERAPEUTICS INC.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

#	Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
1	PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner	2025-02-14 16:15:06	24,245,952 0	24,245,952	Form 13G
2	Redmile Group LLC Green Jeremy 10% Owner	2025-02-14 20:00:35	14,184,495 0	14,184,495	Form 13G
3	PERRY MARK W 10% Owner	2012-03-09 15:52:38	0 4,584,311	4,584,311	Form 4
4	NEW ENTERPRISE ASSOCIATES 11 LP NEA PARTNERS 11 LP NEA 11 GP LLC BASKETT FOREST DRANT RYAN D KOLLURI KRISHNA KITTU SANDELL SCOTT D 10% Owner	2012-03-09 15:55:05	4,584,311 0	4,584,311	Form 4
5	BARRIS PETER J 10% Owner	2012-03-09 15:54:27	0 4,584,311	4,584,311	Form 4
6	KRAMLICH C RICHARD 10% Owner	2012-03-09 15:53:36	0 4,584,311	4,584,311	Form 4
7	NEWHALL CHARLES W III 10% Owner	2012-03-09 15:52:56	0 4,584,311	4,584,311	Form 4
8	CHL Medical Partners II Side Fund L.P. 10% Owner	2007-06-07 13:58:16	2,108,555 1,975,456	4,084,011	Form 4
9	NEW ENTERPRISE ASSOCIATES 11 LP NEA PARTNERS 11 LP NEA 11 GP LLC BARRETT M JAMES BASKETT FOREST DRANT RYAN D KOLLURI KRISHNA KITTU LINEHAN CHARLES M SANDELL SCOTT D TRAINOR III EUGENE A 10% Owner	2007-06-07 20:28:23	3,659,157 0	3,659,157	Form 4
10	Garden State Life Sciences Venture Fund L P 10% Owner	2007-06-07 10:41:25	1,419,762 1,064,822	2,484,584	Form 4
11	PROSPECT VENTURE PARTNERS II LP PROSPECT ASSOCIATES II L P PROSPECT MANAGEMENT CO II LLC TANANBAUM JAMES B SCHNELL DAVID HIRSCH RUSSELL C 10% Owner	2013-01-28 17:13:59	2,240,752 0	2,240,752	Form 13G
12	QUAKER BIO VENTURES LP 10% Owner	2012-02-14 14:33:03	1,429,762 0	1,429,762	Form 13G
13	CHL Medical Partners II L.P. 10% Owner	2010-02-05 14:33:55	1,365,941 0	1,365,941	Form 13G
14	Campbell Bradley L President and CEO	2025-03-18 17:56:44	1,137,282 0	1,137,282	Form 4
15	Crowley John F Executive Chairman	2024-03-15 19:14:06	927,013 0	927,013	Form 4/A
16	Canaan Equity Partners III LLC CANAAN EQUITY III LP CANAAN EQUITY III ENTREPRENEURS LLC BALEN JOHN V GREEN L STEPHEN DEEPAK KAMRA KOPCHINSKY GREGORY RUDNICK SETH RUSSO GUY M YOUNG ERIC A 10% Owner	2010-02-10 16:10:48	552,191 0	552,191	Form 13G
17	Rosenberg Ellen Chief Legal Officer	2025-02-13 17:00:13	507,710 15,000	522,710	Form 4
18	Castelli Jeff Chief Development Officer	2025-02-13 17:19:31	465,476 0	465,476	Form 4
19	Do Hung Chief Science Officer	2021-04-08 20:05:06	448,617 0	448,617	Form 4
20	Quimi Daphne Chief Financial Officer	2023-01-19 18:16:09	398,532 0	398,532	Form 4
21	Harford Simon N.R. Chief Financial Officer	2025-01-06 19:02:18	377,944 0	377,944	Form 4
22	Clark David Michael Chief People Officer	2025-02-13 17:17:19	348,261 0	348,261	Form 4
23	Barth Jay Chief Medical Officer	2020-10-02 16:34:33	177,870 20	177,890	Form 4
24	Dilone Enrique SVP, Technical Operations	2015-06-23 20:09:25	158,598 0	158,598	Form 4
25	LOVE TED W Director	2020-06-08 16:57:03	149,574 0	149,574	Form 4
26	Baird William D III Chief Financial Officer	2018-10-17 18:28:05	141,622 0	141,622	Form 4
27	WHITMAN BURKE W Director	2024-06-07 19:54:51	140,651 0	140,651	Form 4
28	SBLENDORIO GLENN Director	2024-06-07 19:46:14	137,910 0	137,910	Form 4
29	RAAB MICHAEL Director	2024-06-07 19:44:34	137,910 0	137,910	Form 4
30	Bleil Lynn Dorsey Director	2024-06-07 19:49:26	135,994 0	135,994	Form 4
31	Weinhoff Gregory M Director	2008-08-18 16:05:37	0 129,943	129,943	Form 4
32	MCGLYNN MARGARET G Director	2024-06-07 19:41:47	113,603 0	113,603	Form 4
33	Prout Samantha Chief Accounting Officer	2025-02-13 17:22:50	109,441 0	109,441	Form 4
34	WHEELER CRAIG A Director	2024-06-07 19:53:32	106,684 0	106,684	Form 4
35	Ludwig Karin Senior VP, Clinical Research	2007-05-30 19:56:54	106,667 0	106,667	Form 3
36	Patterson Matthew R Acting CEO & President	2011-04-19 15:53:18	106,547 0	106,547	Form 4
37	Lockhart David J Chief Scientific Officer	2013-06-20 16:10:15	100,000 0	100,000	Form 4
38	Gershkowitz Jayne SVP, Chief Patient Advocate	2015-07-01 17:27:09	99,396 0	99,396	Form 4
39	ROBERTS EIRY Director	2024-06-07 19:52:14	98,328 0	98,328	Form 4
40	Kelly Michael Aaron Director	2024-06-07 19:47:57	94,521 0	94,521	Form 4
41	Andrews Kurt J. SVP, Human Resources	2018-07-05 16:25:39	90,469 0	90,469	Form 4
42	Boudes Pol F Chief Medical Officer	2012-06-06 16:44:04	80,000 0	80,000	Form 4
43	Baldry Mark VP Global Marketing	2015-06-04 18:56:39	75,000 0	75,000	Form 4
44	Valenzano Ken SVP, Pharmacology & Biology	2015-07-15 17:05:48	71,687 0	71,687	Form 4
45	ESSNER ROBERT Director	2021-06-14 19:14:06	67,226 0	67,226	Form 4
46	Peist Kenneth VP, Legal & IP	2016-01-06 16:18:25	63,874 0	63,874	Form 4
47	Simon Mark Sr. VP, Business Development	2007-05-30 19:52:19	63,334 0	63,334	Form 3
48	Bloch Stephen M Director	2009-02-12 13:31:12	0 61,700	61,700	Form 4
49	David Allsop SVP International	2015-04-28 17:01:43	50,000 0	50,000	Form 4
50	Kirk John VP, Regulatory Affairs	2015-06-03 19:18:58	45,000 0	45,000	Form 4
51	Schaeffer Orlov S Nicole SVP, HR & Leadership Devt	2012-02-17 14:38:28	45,000 0	45,000	Form 4
52	Branch Douglas A VP, General Counsel & Sec.	2007-05-30 19:47:28	40,002 0	40,002	Form 3
53	Winterbottom Joan SVP, Human Resources	2013-06-20 16:11:11	40,000 0	40,000	Form 4
54	Macaluso Peter M VP & Corporate Counsel	2013-06-20 16:12:21	35,000 0	35,000	Form 4
55	Winkler Robert E VP, Clin Research & Operations	2012-06-06 16:48:12	35,000 0	35,000	Form 4
56	Palling David Sr VP, Technical Operations	2009-06-30 12:53:51	34,040 0	34,040	Form 4
57	Dentzer James E Chief Financial Officer	2009-10-01 13:49:13	32,075 0	32,075	Form 4
58	Licholai Gregory P VP, Medical Affairs	2009-02-05 12:02:54	27,000 0	27,000	Form 4
59	BARER SOL J Director	2016-06-13 14:37:44	20,000 0	20,000	Form 4
60	Shenker Andrew VP, Clinical Research	2009-02-05 12:16:10	18,000 0	18,000	Form 4
61	HAYDEN DONALD J JR Director	2018-06-11 16:44:59	17,807 0	17,807	Form 4
62	John McAdam M VP, Finance & Accounting	2010-06-17 11:48:35	15,000 0	15,000	Form 4
63	Topper James N Director	2014-06-16 12:50:45	15,000 0	15,000	Form 4
64	BARRETT M JAMES Director 10% Owner	2014-06-16 11:35:16	15,000 0	15,000	Form 4
65	Doshi Dipal SVP Strategy & Bus Dev	2015-07-09 18:26:35	14,206 0	14,206	Form 4
66	BARKAS ALEXANDER E Director	2011-06-14 14:42:26	10,000 0	10,000	Form 4
67	NEFF P SHERRILL Director	2010-06-17 09:52:54	10,000 0	10,000	Form 4
68	Gilmore Geoffrey SVP & General Counsel	2012-03-13 13:28:06	10,000 0	10,000	Form 4
69	GLAXOSMITHKLINE PLC Former 10% Owner (1)	2014-10-28 14:35:36	0 0	0	Form 4
70	Yu Julie VP Clinical Ops & Data Mgmt	2015-06-16 20:14:59	0 0	0	Form 4
71	FHM IV LP Frazier Healthcare V LP FHM V LP FHM V LLC FRAZIER HEALTHCARE IV LP FRAZIER AFFILIATES IV LP 10% Owner	2016-03-08 14:35:34	0 0	0	Form 13G
72	Mount Sinai School of Medicine of New York University 10% Owner	2007-06-07 15:44:37	0 0	0	Form 4

Insider Holders & Insider Ownership - AMICUS THERAPEUTICS INC. (FOLD)